|
Gene sets used in this analysis |
||
| Functional pathway |
Number of probe sets (corresponding number of known genes) |
Reference |
|
|
||
| Cytogenetic sets, n = 319 sets |
15–500 (variable) |
Subramanian, et al. [5] |
| Functional sets, n = 522 sets |
15–500 (variable) |
Subramanian, et al. [5] |
| Oncogenic pathways, 5 sets |
Bild, et al. [12] |
|
| Myc |
164 (139) |
|
| Ras |
228 (176) |
|
| E2F3 |
173 (147) |
|
| β-catenin |
54 (42) |
|
| Src |
46 (44) |
|
| Genomic grade index, 1 set |
242 (183) |
Sotiriou, et al. [15] |
| 76-gene prognostic signature, 1 set |
76 (76) |
Wang, et al. [16] |
| Proliferation signature, 1 set |
74 (44) |
Whitfield, et al. [17] |
| ABC transporter gene set, 1 set |
61 (47) |
Szakacs, et al. [18] |
| Mutant p53 signature, 1 set |
25 (21) |
Miller, et al. [13] |
| Estrogen receptor-associated gene set, 1 set |
200 (187) |
Symmans, et al. [14] |
Tordai et al. Breast Cancer Research 2008 10:R37 doi:10.1186/bcr2088 |
||